ondansetron has been researched along with mianserin in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (25.00) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bryce, D; Chalabi, PM; Furman, J; Guarino, KJ; Ives, JL; McLean, S; Nagel, AA; Rosen, T; Roth, RW; Seeger, TF | 1 |
Topliss, JG; Yoshida, F | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Gozlan, H; Hamon, M; Kidd, FJ; Levy, JC; Nielsen, M | 1 |
Lauder, JM; Moiseiwitsch, JR | 1 |
Bhargava, VK; Saha, L | 1 |
Foley, KF; Kast, RE | 1 |
Bhatia, KS; Fowler, JC; Lee, TH; Szabo, ST; Wetsel, WC | 1 |
Arias, C; Spear, NE | 1 |
Koch, H; Nanev, D | 1 |
Lozano, R | 1 |
12 other study(ies) available for ondansetron and mianserin
Article | Year |
---|---|
Synthesis, in vitro binding profile, and central nervous system penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole.
Topics: Animals; Blood-Brain Barrier; Brain; Chemical Phenomena; Chemistry; Glioma; Imidazoles; Mice; Molecular Structure; Neuroblastoma; Serotonin Antagonists; Thiazoles; Tumor Cells, Cultured | 1990 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
Topics: Aged; Aged, 80 and over; Animals; Benzamides; Binding Sites; Brain; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Female; Glioma; Hippocampus; Humans; Male; Mianserin; Ondansetron; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Spinal Cord; Stereoisomerism; Tissue Distribution; Tumor Cells, Cultured | 1993 |
Regulation of gene expression in cultured embryonic mouse mandibular mesenchyme by serotonin antagonists.
Topics: Aggrecans; Animals; Calcium-Binding Proteins; Chondroitin Sulfate Proteoglycans; Culture Techniques; Extracellular Matrix Proteins; Female; Gene Expression Regulation, Developmental; Lectins, C-Type; Mandible; Mesoderm; Mianserin; Mice; Mice, Inbred ICR; Nerve Growth Factors; Ondansetron; Piperazines; Pregnancy; Proteoglycans; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Serotonin Antagonists; Tenascin | 1997 |
Serotonergic mechanism in imipramine induced antinociception in rat tail flick test.
Topics: Adrenergic Uptake Inhibitors; Animals; Fenclonine; Imipramine; Male; Mianserin; Ondansetron; Pain Measurement; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists | 2001 |
Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects.
Topics: Antiemetics; Antineoplastic Agents; Benzodiazepines; Cachexia; Humans; Mianserin; Mirtazapine; Nausea; Neoplasms; Olanzapine; Ondansetron; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists | 2007 |
Reversal of long-term methamphetamine sensitization by combination of pergolide with ondansetron or ketanserin, but not mirtazapine.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Infusion Pumps, Implantable; Ketanserin; Male; Methamphetamine; Mianserin; Mirtazapine; Ondansetron; Pergolide; Rats; Rats, Sprague-Dawley | 2011 |
Mianserin, but not ondansetron, reduces the locomotor stimulating effect of ethanol in preweanling rats.
Topics: Animals; Animals, Newborn; Dose-Response Relationship, Drug; Ethanol; Female; Male; Mianserin; Motor Activity; Ondansetron; Rats; Rats, Sprague-Dawley; Weaning | 2011 |
Important interaction between mirtazapine and ondansetron.
Topics: Aged; Antidepressive Agents, Tricyclic; Antiemetics; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Mianserin; Mirtazapine; Ondansetron | 2012 |
Mirtazapine and ondansetron: a dual pharmacodynamic and pharmacokinetic interaction.
Topics: Antidepressive Agents, Tricyclic; Antiemetics; Drug Interactions; Humans; Male; Mianserin; Ondansetron | 2013 |